Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Tolerance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07819071
What this trial is testing

EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITIS

Who this might be right for
Atopic Dermatitis (AD)
Pierre Fabre Dermo Cosmetique 33
Post-approval studies (Phase 4)Study completedNCT00926367
What this trial is testing

Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications

Who this might be right for
Acne Vulgaris
Stiefel, a GSK Company 52
Early research (Phase 1)Study completedNCT06883695
What this trial is testing

A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis
Guangdong Hengrui Pharmaceutical Co., Ltd 40
Not applicableStudy completedNCT00722189
What this trial is testing

Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses

Who this might be right for
Skin Mycoses
LEO Pharma 900
Early research (Phase 1)Study completedNCT02620293
What this trial is testing

A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin

Who this might be right for
Eczema
Reckitt Benckiser Healthcare (UK) Limited 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT02866565
What this trial is testing

Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERs

Who this might be right for
Diabetic Foot Ulcer
Assistance Publique Hopitaux De Marseille 45
Large-scale testing (Phase 3)Not Yet RecruitingNCT05698979
What this trial is testing

Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease

Who this might be right for
Buerger DiseaseRaynaud Syndrome
University Hospital, Toulouse 8
Not applicableStudy completedNCT03640832
What this trial is testing

A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin

Who this might be right for
Skin Care
GlaxoSmithKline 90
Not applicableWithdrawnNCT04761978
What this trial is testing

Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
University Hospital, Lille
Not applicableStudy completedNCT03155217
What this trial is testing

Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old

Who this might be right for
Metastatic Melanoma
University Hospital, Montpellier 358
Testing effectiveness (Phase 2)Study completedNCT01988506
What this trial is testing

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more
Assistance Publique - Hôpitaux de Paris 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07596212
What this trial is testing

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

Who this might be right for
Early-stage Breast CancerHypoactive Sexual Desire DisorderHormone Receptor Positive Breast Carcinoma+1 more
University of Illinois at Chicago 100
Testing effectiveness (Phase 2)Study completedNCT00761215
What this trial is testing

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

Who this might be right for
Skin Diseases, InfectiousSkin Diseases, Bacterial
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 192
Not applicableStudy completedNCT03730818
What this trial is testing

Water-based Versus Land-based Exercise for Breast Cancer Survivors

Who this might be right for
Breast Cancer
Universitat Pompeu Fabra 28
Not applicableStudy completedNCT00624676
What this trial is testing

Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris

Who this might be right for
Acne Vulgaris
Cosmetique Active International 80
Not applicableStudy completedNCT03820076
What this trial is testing

Safety Study of AZT-04 for Cosmetic Use

Who this might be right for
Study of Three Doses of AZT-04 for Skin Appearance
Azitra Inc. 21
Not applicableStudy completedNCT04239768
What this trial is testing

Efficacy of an Antiage Aesthetic Treatment for the Middle and Inferior Third of the Face

Who this might be right for
Face Skin Laxity
Derming SRL 24
Not applicableStudy completedNCT05168397
What this trial is testing

Sunscreen Efficacy Against the Reccurence of Lesions Post-sun Exposure in Acneic Subjects

Who this might be right for
Acne
Pierre Fabre Dermo Cosmetique 45
Not applicableStudy completedNCT05625815
What this trial is testing

Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots.

Who this might be right for
Solar LentigoSenile LentigoPost-inflammatory Hyperpigmentation
Cryonove Pharma 32
Post-approval studies (Phase 4)Study completedNCT01660321
What this trial is testing

Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation

Who this might be right for
Pediculosis
ParaPRO LLC 26
Next Page